Hercules Capital: Why It Deserves A Premium To NAV Valuation (NYSE:HTGC)
· seekingalpha.com
Hercules Capital (HTGC) outlook: biotech/healthcare rebound, rate upside to NII/EPS, low-cost edge, and attractive valuation vs BDC peers—read now.
Since my last Neutral/Hold update on the stock, after a period of going sideways Hercules Capital ( HTGC ) has started to do well, both in terms of price perfor...